
Amy E. Juedes
Examiner (ID: 8010, Phone: (571)272-4471 , Office: P/1644 )
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1644 |
| Total Applications | 1273 |
| Issued Applications | 443 |
| Pending Applications | 154 |
| Abandoned Applications | 706 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6095323
[patent_doc_number] => 20110002930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-06
[patent_title] => 'Activated T Cells'
[patent_app_type] => utility
[patent_app_number] => 12/746581
[patent_app_country] => US
[patent_app_date] => 2008-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 17094
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20110002930.pdf
[firstpage_image] =>[orig_patent_app_number] => 12746581
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/746581 | Activated T Cells | Dec 7, 2008 | Abandoned |
Array
(
[id] => 5574956
[patent_doc_number] => 20090142317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-04
[patent_title] => 'PROCESS FOR REDUCING EFFECTS OF GRAFT VERSUS HOST DISEASE USING EX VIVO EXPANDED CD4+CD25+ REGULATORY T CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/325464
[patent_app_country] => US
[patent_app_date] => 2008-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 3034
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20090142317.pdf
[firstpage_image] =>[orig_patent_app_number] => 12325464
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/325464 | PROCESS FOR REDUCING EFFECTS OF GRAFT VERSUS HOST DISEASE USING EX VIVO EXPANDED CD4+CD25+ REGULATORY T CELLS | Nov 30, 2008 | Abandoned |
Array
(
[id] => 6550811
[patent_doc_number] => 20100233197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'METHOD FOR GENERATING TOLEROGENIC DENDRITIC CELLS EMPLOYING DECREASED TEMPERATURE'
[patent_app_type] => utility
[patent_app_number] => 12/741795
[patent_app_country] => US
[patent_app_date] => 2008-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9348
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20100233197.pdf
[firstpage_image] =>[orig_patent_app_number] => 12741795
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/741795 | METHOD FOR GENERATING TOLEROGENIC DENDRITIC CELLS EMPLOYING DECREASED TEMPERATURE | Nov 12, 2008 | Abandoned |
Array
(
[id] => 6434409
[patent_doc_number] => 20100278873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-04
[patent_title] => 'STIMULATION OF ANTI-TUMOR IMMUNITY USING DENDRITIC CELL/TUMOR CELL FUSIONS AND ANTI-CD3/CD28'
[patent_app_type] => utility
[patent_app_number] => 12/741472
[patent_app_country] => US
[patent_app_date] => 2008-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 27760
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0278/20100278873.pdf
[firstpage_image] =>[orig_patent_app_number] => 12741472
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/741472 | STIMULATION OF ANTI-TUMOR IMMUNITY USING DENDRITIC CELL/TUMOR CELL FUSIONS AND ANTI-CD3/CD28 | Nov 6, 2008 | Abandoned |
Array
(
[id] => 8328225
[patent_doc_number] => 08236318
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-07
[patent_title] => 'Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)'
[patent_app_type] => utility
[patent_app_number] => 12/266745
[patent_app_country] => US
[patent_app_date] => 2008-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 28741
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 255
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12266745
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/266745 | Antibodies that bind human dendritic and epithelial cell 205 (DEC-205) | Nov 6, 2008 | Issued |
Array
(
[id] => 5563594
[patent_doc_number] => 20090136446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'INDUCTION OF REGULATORY T CELL-RESISTANT HELPER CD4+ T CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/262831
[patent_app_country] => US
[patent_app_date] => 2008-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19993
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20090136446.pdf
[firstpage_image] =>[orig_patent_app_number] => 12262831
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/262831 | INDUCTION OF REGULATORY T CELL-RESISTANT HELPER CD4+ T CELLS | Oct 30, 2008 | Abandoned |
Array
(
[id] => 5322956
[patent_doc_number] => 20090060946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'Activation of antigen-specific T cells by virus/antigen-treated dendritic cells'
[patent_app_type] => utility
[patent_app_number] => 12/288553
[patent_app_country] => US
[patent_app_date] => 2008-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7240
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20090060946.pdf
[firstpage_image] =>[orig_patent_app_number] => 12288553
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/288553 | Activation of antigen-specific T cells by virus/antigen-treated dendritic cells | Oct 20, 2008 | Abandoned |
Array
(
[id] => 5993044
[patent_doc_number] => 20110014697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'Method and Kit for Rapid Isolation of Human Foxp3+ Treg Cells'
[patent_app_type] => utility
[patent_app_number] => 12/682674
[patent_app_country] => US
[patent_app_date] => 2008-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10637
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20110014697.pdf
[firstpage_image] =>[orig_patent_app_number] => 12682674
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/682674 | Method and Kit for Rapid Isolation of Human Foxp3+ Treg Cells | Oct 9, 2008 | Abandoned |
Array
(
[id] => 6273135
[patent_doc_number] => 20100255507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'ANTIBODIES AND OTHER LIGANDS DIRECTED AGAINST KIR2DL4 RECEPTOR FOR PRODUCTION OF INTERFERON GAMMA'
[patent_app_type] => utility
[patent_app_number] => 12/249703
[patent_app_country] => US
[patent_app_date] => 2008-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14245
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20100255507.pdf
[firstpage_image] =>[orig_patent_app_number] => 12249703
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/249703 | ANTIBODIES AND OTHER LIGANDS DIRECTED AGAINST KIR2DL4 RECEPTOR FOR PRODUCTION OF INTERFERON GAMMA | Oct 9, 2008 | Abandoned |
Array
(
[id] => 5271564
[patent_doc_number] => 20090075340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'Kir-Binding Agents and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/244101
[patent_app_country] => US
[patent_app_date] => 2008-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 35193
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20090075340.pdf
[firstpage_image] =>[orig_patent_app_number] => 12244101
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/244101 | KIR-binding agents and methods of use thereof | Oct 1, 2008 | Issued |
Array
(
[id] => 5984596
[patent_doc_number] => 20110097334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'Novel Marker Genes for Regulatory T Cells from Human Blood'
[patent_app_type] => utility
[patent_app_number] => 12/681263
[patent_app_country] => US
[patent_app_date] => 2008-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 50259
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20110097334.pdf
[firstpage_image] =>[orig_patent_app_number] => 12681263
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/681263 | Marker genes for regulatory T cells from human blood | Oct 1, 2008 | Issued |
Array
(
[id] => 7774772
[patent_doc_number] => 08119775
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-21
[patent_title] => 'Human anti-KIR antibodies'
[patent_app_type] => utility
[patent_app_number] => 12/244170
[patent_app_country] => US
[patent_app_date] => 2008-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 48846
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/119/08119775.pdf
[firstpage_image] =>[orig_patent_app_number] => 12244170
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/244170 | Human anti-KIR antibodies | Oct 1, 2008 | Issued |
Array
(
[id] => 6228803
[patent_doc_number] => 20100183541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'Methods of Treating Autoimmune Diseases'
[patent_app_type] => utility
[patent_app_number] => 12/241345
[patent_app_country] => US
[patent_app_date] => 2008-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 9626
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20100183541.pdf
[firstpage_image] =>[orig_patent_app_number] => 12241345
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/241345 | Methods of Treating Autoimmune Diseases | Sep 29, 2008 | Abandoned |
Array
(
[id] => 9059702
[patent_doc_number] => 08546137
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-01
[patent_title] => 'Inhibition of dendritic cell-driven regulatory T cell activation and potentiation of tumor antigen-specific T cell responses by interleukin-15 and MAP kinase inhibitor'
[patent_app_type] => utility
[patent_app_number] => 12/286122
[patent_app_country] => US
[patent_app_date] => 2008-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11430
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12286122
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/286122 | Inhibition of dendritic cell-driven regulatory T cell activation and potentiation of tumor antigen-specific T cell responses by interleukin-15 and MAP kinase inhibitor | Sep 26, 2008 | Issued |
Array
(
[id] => 6392484
[patent_doc_number] => 20100303868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-02
[patent_title] => 'EX VIVO, FAST AND EFFICIENT PROCESS TO OBTAIN ACTIVATED ANTIGEN-PRESENTING CELLS THAT ARE USEFUL FOR THERAPIES AGAINST CANCER AND IMMUNE SYSTEM-RELATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/680709
[patent_app_country] => US
[patent_app_date] => 2008-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6680
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0303/20100303868.pdf
[firstpage_image] =>[orig_patent_app_number] => 12680709
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/680709 | EX VIVO, FAST AND EFFICIENT PROCESS TO OBTAIN ACTIVATED ANTIGEN-PRESENTING CELLS THAT ARE USEFUL FOR THERAPIES AGAINST CANCER AND IMMUNE SYSTEM-RELATED DISEASES | Sep 25, 2008 | Abandoned |
Array
(
[id] => 5367144
[patent_doc_number] => 20090304703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'Compositions and methods for the diagnosis and treatment of immune disorders'
[patent_app_type] => utility
[patent_app_number] => 12/284648
[patent_app_country] => US
[patent_app_date] => 2008-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 61701
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0304/20090304703.pdf
[firstpage_image] =>[orig_patent_app_number] => 12284648
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/284648 | Compositions and methods for the diagnosis and treatment of immune disorders | Sep 23, 2008 | Issued |
Array
(
[id] => 7697142
[patent_doc_number] => 20110229448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => ' METHOD FOR IDENTIFYING ANTIGEN-SPECIFIC REGULATORY T CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/678853
[patent_app_country] => US
[patent_app_date] => 2008-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17115
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20110229448.pdf
[firstpage_image] =>[orig_patent_app_number] => 12678853
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/678853 | Method for identifying antigen-specific regulatory T cells | Sep 21, 2008 | Issued |
Array
(
[id] => 6519434
[patent_doc_number] => 20100203068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'METHODS OF SWITCHING THE PHENOTYPE OF T CELLS BY TRANSGENIC LINEAGE FACTOR FOXP3'
[patent_app_type] => utility
[patent_app_number] => 12/678724
[patent_app_country] => US
[patent_app_date] => 2008-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 24471
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20100203068.pdf
[firstpage_image] =>[orig_patent_app_number] => 12678724
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/678724 | METHODS OF SWITCHING THE PHENOTYPE OF T CELLS BY TRANSGENIC LINEAGE FACTOR FOXP3 | Sep 16, 2008 | Abandoned |
Array
(
[id] => 6500444
[patent_doc_number] => 20100215674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'ENHANCING THE T-CELLS STIMULATORY CAPACITY OF HUMAN ANTIGEN PRESENTING CELLS AND THEIR USE IN VACCINATION'
[patent_app_type] => utility
[patent_app_number] => 12/677476
[patent_app_country] => US
[patent_app_date] => 2008-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 17430
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20100215674.pdf
[firstpage_image] =>[orig_patent_app_number] => 12677476
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/677476 | Enhancing the T-cells stimulatory capacity of human antigen presenting cells and their use in vaccination | Sep 11, 2008 | Issued |
Array
(
[id] => 6440356
[patent_doc_number] => 20100279409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-04
[patent_title] => 'METHOD FOR MODIFYING CELLUAR IMMUNE RESONSE BY MODULATING ACTIVIN ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 12/733670
[patent_app_country] => US
[patent_app_date] => 2008-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7030
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0279/20100279409.pdf
[firstpage_image] =>[orig_patent_app_number] => 12733670
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/733670 | METHOD FOR MODIFYING CELLUAR IMMUNE RESONSE BY MODULATING ACTIVIN ACTIVITY | Sep 10, 2008 | Abandoned |